1. Xiaosheng Liang, Zhuming Xue, Yangwu Zheng, Linpeng Li, Lijun Zhou, Lin Cao*, Yi Zou*. Selenium supplementation enhanced the expression of selenoproteins in hippocampus and played a neuroprotective role in LPS-induced neuroinflammation. Int J Biol Macromol, 2023: 123740. (IF: 8.02, 一区TOP）
2.Yaohui Liang, Chao Song, Jieli Li, Ting Li, Chunlei Zhang and Yi Zou*. Morphometric analysis of the size‑adjusted linear dimensions of the skull landmarks revealed craniofacial dysmorphology in Mid1‑cKO mice. BMC genomics, 2023, 24(1): 1-15. (IF:4.5, 二区TOP)
3.Xiaosheng Liang, Ting Liu, Linpeng Li, Jieli Li, Shufang Li, Ke Zeng, Chao Song, Tianfeng Chen*, Yi Zou*. Translational selenium nanotherapeutics counter-acts multiple risk factors to improve surgery-induced cognitive impairment. Chem Eng J, 2022: 135984. (IF:16.7, 一区TOP)
4. Shufang Li, Linpeng Li, Jieli Li, Xiaosheng Liang, Chao Song and Yi Zou*. miR-203, fine-tunning neuroinflammation by juggling different components of NF‐κB signaling. J Neuroinflammation, 2022, 19(1): 1-16. (IF: 9.5, 一区TOP)
5. Linpeng Li, Song Chao, Ma Yi*, Yi Zou*. “Half-wet-half-dry”: an innovation in undergraduate laboratory classes to generate transgenic mouse models using CRISPR/Cas9 and computer simulation. J Biol Educ, 2022: 1-9.
6. Shufang Li, Xiaosheng Liang, Yaohui Liang, Linpeng Li, Jia Gan, Lin Cao, Yi Zou*. Identification of the transcription factor, AFF4, as a new target of miR-203 in CNS. Int J Biol Macromol, 2021(181): 919-927. (IF: 8.02, 一区TOP）
7. Yingying Qiao, Yuan Zhou, Chao Song, Xin Zhang, Yi Zou*. MID1 and MID2 regulate cell migration and epithelial-mesenchymal transition via modulating Wnt/β -catenin signaling. Ann Transl Med, 2020, 8 (16): 1020-1033.
8. Yi Zou ; Haiping Tan; Yuanfeng Zhao; Yuan Zhou; Lin Cao*.Expressionand selective activation of somatostatin receptor subtypes induces cell cyclearrest in cancer cells, Oncol Lett, 2019, 17: 1723-1731.
9. Bijun Li ; Tianhong Zhou; Yi Zou*. MID1/MID2 expression incraniofacialdevelopment and a literature review of X-link Opitz syndrome, molecular genetics and genomic medicine, 2016.1.1, 4(1): 95-105.